HERON THERAPEUTICS, INC. /DE/ Quarterly Interest Expense in USD from Q1 2012 to Q1 2017

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Heron Therapeutics, Inc. /De/ annual/quarterly Interest Expense history and growth rate from Q1 2012 to Q1 2017.
  • Heron Therapeutics, Inc. /De/ Interest Expense for the quarter ending March 31, 2017 was $1.03M, a 674% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ Interest Expense for the twelve months ending March 31, 2017 was $3.44M, a 301% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Interest Expense for 2023 was $3.87M, a 56.3% increase from 2022.
  • Heron Therapeutics, Inc. /De/ annual Interest Expense for 2022 was $2.47M, a 2.66% increase from 2021.
  • Heron Therapeutics, Inc. /De/ annual Interest Expense for 2021 was $2.41M, a 26.8% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2017 $3.44M $1.03M +$897K +674% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $2.55M $1.27M +$1.02M +414% Oct 1, 2016 Dec 31, 2016 10-K 2017-02-23
Q3 2016 $1.52M $886K +$644K +266% Jul 1, 2016 Sep 30, 2016 10-K 2017-02-23
Q2 2016 $879K $257K +$20K +8.44% Apr 1, 2016 Jun 30, 2016 10-K 2017-02-23
Q1 2016 $859K $133K -$99K -42.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $958K $247K +$20K +8.81% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-23
Q3 2015 $938K $242K +$18K +8.04% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-23
Q2 2015 $920K $237K +$17K +7.73% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-23
Q1 2015 $903K $232K +$16K +7.41% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-23
Q4 2014 $887K $227K +$15K +7.08% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-19
Q3 2014 $872K $224K +$15K +7.18% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-19
Q2 2014 $857K $220K +$15K +7.32% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-19
Q1 2014 $842K $216K +$15K +7.46% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-19
Q4 2013 $827K $212K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-13
Q3 2013 $209K Jul 1, 2013 Sep 30, 2013 10-K 2015-03-13
Q2 2013 $205K Apr 1, 2013 Jun 30, 2013 10-K 2015-03-13
Q1 2013 $201K -$1K -0.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2012 $202K Jan 1, 2012 Mar 31, 2012 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.